Records containing: Narcolepsy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-08-27A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low-Sodium Oxybate Oral Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Years With Idiopathic Hypersomnia or Narcolepsy
-
CLINICAL_TRIALS study results posted · 2026-06-30Behavioral Treatment of Narcolepsy-Related Nightmares
-
CLINICAL_TRIALS study record update · 2026-04-24An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to Xywav
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Samelisant Compared to Placebo in Patients With Narcolepsy With or Without Cataplexy
-
CLINICAL_TRIALS study record update · 2026-04-14A Two-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Sleep Latency Effects of MK-6552 in Participants With Narcolepsy Type 1
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06A Phase 1b, Randomized, Double-blind, Sponsor-Unblinded, Placebo-Controlled 4-Way Crossover Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 in Participants With Narcolepsy Type 1
-
CLINICAL_TRIALS study record update · 2026-03-25A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
-
CLINICAL_TRIALS study record update · 2026-03-24Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
-
CLINICAL_TRIALS study record update · 2026-03-10Imagery Rehearsal Therapy for the Treatment of Nightmares in Narcolepsy: A Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-02-13A Prospective, Multicenter, Observational Study of LUMRYZ Used in Clinical Practice for the Treatment of Narcolepsy
-
CLINICAL_TRIALS study record update · 2026-01-22Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
-
CLINICAL_TRIALS study record update · 2025-12-19Is There a Change in the Total Metabolism Over 24 Hours for Narcoleptic Children That Could Explain Their Tendency to Obesity?
-
CLINICAL_TRIALS study record update · 2025-12-12A Phase 1b, Open-Label Study of HBS-201 (Pitolisant Delayed-release) in Adult Participants With Narcolepsy
-
CLINICAL_TRIALS study record update · 2025-11-13A Study to Assess the Long-term Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects With Narcolepsy
-
CLINICAL_TRIALS study record update · 2025-10-02Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
-
CLINICAL_TRIALS study record update · 2025-08-05WAKIX® (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring
-
CLINICAL_TRIALS study record update · 2025-07-17A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low-Sodium Oxybate Oral Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Years With Idiopathic Hypersomnia or Narcolepsy
-
CLINICAL_TRIALS study record update · 2025-06-29Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
-
CLINICAL_TRIALS study record update · 2025-03-19A Randomized, Double-Blind, Placebo-Controlled, Multi- Center Study to Assess the Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects With Narcolepsy
-
CLINICAL_TRIALS study record update · 2025-02-28A Phase II, Double-blind, Parallel-group Comparative Study 2 of TS-091 in Patients with Narcolepsy
-
CLINICAL_TRIALS study record update · 2025-02-21Decision Making Among Older Adults: the AUTO Study
-
CLINICAL_TRIALS study record update · 2025-02-14The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
-
CLINICAL_TRIALS study record update · 2025-02-13Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale (PN-PROS)
-
CLINICAL_TRIALS study record update · 2025-01-22Genetic and Clinical Characterization of Type 1 and 2 Narcolepsy in Adult and Pediatric Black and North African Populations
-
CLINICAL_TRIALS study record update · 2025-01-13A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy